These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [New hormonal treatments of metastatic prostatic cancer. Review of the literature]. Dubost JJ, Sauvezie B, Ristori JM, Thevenet JP, Rampon S. Rev Rhum Mal Osteoartic; 1985 Oct 01; 52(10):577-85. PubMed ID: 3909364 [No Abstract] [Full Text] [Related]
7. [Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer]. Rusakov IG, Alekseev BIa. Urologiia; 2002 Oct 01; (5):23-6. PubMed ID: 12402771 [No Abstract] [Full Text] [Related]
11. Castration-resistant prostate cancer--hormone therapy redux. Tolcher AW, Cooper J. J Clin Oncol; 2010 Mar 20; 28(9):1447-9. PubMed ID: 20159817 [No Abstract] [Full Text] [Related]
12. Systemic therapeutic strategies for prostate cancer. Nelson WG. Clin Adv Hematol Oncol; 2005 Aug 20; 3(8):619-21. PubMed ID: 16167046 [No Abstract] [Full Text] [Related]
13. New drugs in the management of advanced prostate cancer. Kelly WK. Cancer J; 2008 Aug 20; 14(1):10. PubMed ID: 18303476 [No Abstract] [Full Text] [Related]
14. [Castration of prostate cancer patients and cognition]. Portin R, Koskinen A, Helenius H, Nurmi M, Salminen E. Duodecim; 2005 Aug 20; 121(16):1784-5. PubMed ID: 16268226 [No Abstract] [Full Text] [Related]
18. [Metastatic cancer of the prostate: course, diagnosis and therapeutic management]. Wisard M, Gabellon S. Rev Med Suisse Romande; 1995 Mar 20; 115(3):241-7. PubMed ID: 7777765 [No Abstract] [Full Text] [Related]